Masters, Arthur M.
July 1971
Angiology;Jul/Aug1971, Vol. 22 Issue 7, p421
Academic Journal
Presents views of an internist on the controversy surrounding the medical versus surgical treatment of coronary disease. Survival rate of patients undergoing a medical and surgical treatment; Comments on the monotony of surgical procedures; Recourse to coronary angiography in cases in which the diagnosis is doubtful.


Related Articles

  • Should patients with unstable coronary syndromes routinely undergo cardiac catheterization and appropriate revascularization? Gazewood, John // Journal of Family Practice;Sep2001, Vol. 50 Issue 9, p739 

    The article discusses research being done on comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. It references a study by C. P. Cannon et al published in the 2001 issue of the "New...

  • Is no news good news? Organized follow-up, an absolute necessity for the evaluation of myocardial revascularization Wouters, Constantijn W.; Noyez, Luc // European Journal of Cardio-Thoracic Surgery;Oct2004, Vol. 26 Issue 4, p667 

    Objective: The objective of this study is to find out whether follow-up information is registered by a non-organized follow-up representative for mortality and morbidity after myocardial revascularization. Methods: The follow-up information registered by an organized (OFU) and a non-organized...

  • Estudo retrospectivo das complicações intra-operatórias na cirurgia de revascularização do rniocárdio. Carvalho, Ariana Rodrigues Silva; Matsuda, Laura Misue; Carvalho, Mauro Sérgio Stateri; Almeida, Rui; Schneider, Deborah; Piccoli, Marister // Revista Eletronica de Enfermagem;2008, Vol. 10 Issue 4, p1057 

    The intra-operative complications in the myocardium revascularization (MRC) when previously known can lead the care applied in the operating theater, supporting the Intensive Therapy Unit continuation and so during the hospitalization. When the crew is aware of these complications suffered by...

  • Drugs are as good as PCI in stable coronary artery disease. Mayor, Susan // BMJ: British Medical Journal (International Edition);4/7/2007, Vol. 334 Issue 7596, p713 

    The article states that a drug treatment with lifestyle intervention offers no less risk of death, myocardial infarction, or cardiovascular events than percutaneous coronary intervention for patients with stable coronary artery disease. This finding was achieved through a prospective study,...

  • Spotlight on Abciximab in Patients with Ischemic Heart Disease Undergoing Percutaneous Coronary Revascularization. Tim Ibbotson; Jane K. McGavin; Karen L. Goa // American Journal of Cardiovascular Drugs;2003, Vol. 3 Issue 5, p381 

    Abciximab (Reopro®) is an antibody fragment that dose-dependently inhibits platelet aggregation and leucocyte adhesion by binding to the glycoprotein (GP) IIb/IIIa, vitronectin and Mac-1 receptors. Abciximab (0.25 mg/kg bolus plus infusion of 0.125 µg/kg/min for 12 hours) showed greater...

  • Racial/Ethnic Variations in Physician Recommendations for Cardiac Revascularization. Ibrahim, Said A.; Whittle, Jeff; Bean-Mayberry, Bevanne; Kelley, Mary E.; Good, Chester; Conigliaro, Joseph // American Journal of Public Health;Oct2003, Vol. 93 Issue 10, p1689 

    Objectives. We sought to examine whether physician recommendations for cardiac revascularization vary according to patient race. Methods. We studied patients scheduled for coronary angiography at 2 hospitals, one public and one private, between November 1997 and June 1999. Cardiologists were...

  • Guidelines praise new tech, but give stents short shrift. BROSKY, JOHN // Medical Device Daily;9/2/2010, Vol. 14 Issue 171, p1 

    The article reports that new guidelines for myocardial revascularization has been released by the European Society of Cardiology (ESC) and the European Association of Cardio-Thoracic Surgeons (EACTS). Published in the online issue of the "European Heart Journal," the guidelines recommended...

  • Off-pump CABG no better for cognitive function.  // Cardiovascular Device Update;Mar2007, Vol. 13 Issue 3, p18 

    The article discusses a study conducted by researchers at the University of Medical Center Utrecht on off-pump coronary artery bypass surgery (CABG). A known side effect of bypass surgery is a decline in cognitive function. Researchers at the university have discovered that the off-pump...

  • Myocardial Revascularization with a Free Skeletal Muscle Flap. Beyer, M.; Hoffer, H.; Beyer, U.; Hannekum, A. // Vascular Surgery;Nov/Dec1996, Vol. 30 Issue 6, p537 

    Based on encouraging experimental evidence, a new myocardial revascularization procedure was, for the first time, used on a sixty-six-year-old patient. This patient suffered from unstable angina (NYHA class III-IV). He had diffuse peripheral coronary artery stenosis (three-vessel disease)....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics